-
Diagnostics World News Brief | Credo Diagnostics Biomedical announced they are now finalizing a rapid point-of-care molecular test to detect the novel coronavirus in 20 minutes.
Feb 26, 2020
-
Diagnostics World News| Radiology is increasingly the key to synthesizing real world evidence with sufficient quality to shape drug performance. As a diagnostic toolset, imaging is one of the oldest and most widely used and clearly interpreted methods for measurement of outcomes. It is regularly used to measure disease progression and to determine the effectiveness of medical interventions. Imaging is also a common mechanism for early identification of disease that can be automated or extended through artificial intelligence (AI).
Feb 20, 2020
-
Diagnostics World News | Some big investments are driving CRISPR-based diagnostics, cell therapies, sepsis diagnostics and more this year.
Feb 19, 2020
-
Diagnostics World News | CRISPR applications are exploding, and Can Dincer, with the Freiburg Center for Interactive Materials and Bioinspired Technologies (FIT) and Department of Microsystems Engineering (IMTEK) at the University of Freiburg in Germany, sees uniquely powerful applications for point-of-care diagnostics.
Feb 18, 2020
-
Diagnostics World News | The same technology that propels the world’s fastest electric train at speeds up to 267 miles per hour is now being used for the first time to levitate proteins in plasma for diagnostic purposes—and tease out differences between healthy and diseased plasma donors.
Feb 14, 2020
-
Diagnostics World News | Angela Pia Sanzone, Blood Biomarkers Group Leader, Advanced Therapies Division, National Institute for Biological Standards and Control (NIBSC), UK, is working with the World Health Organization on international reference standards for ctDNA that will enable harmonized reporting in diagnostics and patient monitoring.
Feb 11, 2020
-
Diagnostics World News Contributed Commentary | In order to achieve the goal of truly tailoring therapy regimens to patient’s molecular profiles, it’s imperative that we overcome challenges and move into the next era of biomarker and diagnostic development.
Feb 7, 2020
-
Diagnostics World News Brief | The diagnostic community has been quick to respond to the recent outbreak of coronavirus that originated in Wuhan, China. Companies have announced commitments to combating the virus, either through funding or technology application.
Feb 6, 2020
-
Diagnostics World News | The FDA’s Director of the Center for Biologics Evaluation and Research discusses the obstacles in developing gene therapies, emerging developments in the field, and the regulatory landscape surrounding personalized therapeutics.
Feb 5, 2020